Sage Therapeutics is a biopharmaceutical company headquartered in Cambridge, Massachusetts and founded in 2010 by Douglas Covey and Steven Paul. The company develops medicines and therapies to treat disorders of the central nervous system.
On October 18, 2011 Sage Therapeutics closed their series A funding round with $35 million in funding from Third Rock Ventures.
SAGE Therapeutics raises a $38,000,000 series C round from EcoR1 Capital, OrbiMed Advisors and Foresite Capital.
SAGE Therapeutics raises a $20,000,000 series B round from ARCH Venture Partners and Third Rock Ventures.
SAGE Therapeutics was founded by Douglas Covey and Steven Paul.
Chief Scientific Officer
Senior Vice President, Regulatory Affairs and Quality Assurance
Senior Vice President, people and Organizational Strategy
Senior Vice President, Technical Operations
CEO & Member of Board of Directors
Chief Research Officer
Chief Financial Officer
Chief Business Officer
Chief Medical Officer
Co-Founder & Board Member
Five things you don’t know about Jeff Jonas, CEO of Sage Therapeutics
Sage Therapeutics CEO: Have to weigh investor returns but will price postpartum drug 'fairly'
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.